IBDEI0FV ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7680,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,7680,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,7680,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,7681,0)
 ;;=414.01^^55^587^21
 ;;^UTILITY(U,$J,358.3,7681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7681,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,7681,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,7681,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,7682,0)
 ;;=311.^^55^587^22
 ;;^UTILITY(U,$J,358.3,7682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7682,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,7682,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,7682,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,7683,0)
 ;;=250.01^^55^587^23
 ;;^UTILITY(U,$J,358.3,7683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7683,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,7683,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,7683,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,7684,0)
 ;;=250.00^^55^587^24
 ;;^UTILITY(U,$J,358.3,7684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7684,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,7684,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,7684,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,7685,0)
 ;;=305.90^^55^587^26
 ;;^UTILITY(U,$J,358.3,7685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7685,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,7685,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,7685,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,7686,0)
 ;;=305.93^^55^587^25
 ;;^UTILITY(U,$J,358.3,7686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7686,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,7686,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,7686,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,7687,0)
 ;;=796.2^^55^587^28
 ;;^UTILITY(U,$J,358.3,7687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7687,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,7687,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,7687,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,7688,0)
 ;;=607.84^^55^587^29
 ;;^UTILITY(U,$J,358.3,7688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7688,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,7688,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,7688,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,7689,0)
 ;;=530.81^^55^587^30
 ;;^UTILITY(U,$J,358.3,7689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7689,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,7689,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,7689,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,7690,0)
 ;;=389.9^^55^587^32
 ;;^UTILITY(U,$J,358.3,7690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7690,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,7690,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,7690,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,7691,0)
 ;;=784.0^^55^587^31
 ;;^UTILITY(U,$J,358.3,7691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7691,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,7691,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,7691,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,7692,0)
 ;;=070.54^^55^587^33
 ;;^UTILITY(U,$J,358.3,7692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7692,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,7692,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,7692,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,7693,0)
 ;;=272.4^^55^587^34
 ;;^UTILITY(U,$J,358.3,7693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7693,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,7693,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,7693,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,7694,0)
 ;;=272.2^^55^587^35
 ;;^UTILITY(U,$J,358.3,7694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7694,1,4,0)
 ;;=4^272.2
